A-Alpha Bio
The protein-protein interaction company.
Seattle, United States · Founded 2017 · $46.0M raised
- Headquarters
- Seattle, Washington
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- aalphabio.com
- Total Funding
- $46.0M
- Last Round
- $22.4M Series AJul 2023
- Rounds
- 4
About
A-Alpha Bio is a Seattle-based biotechnology company using its AlphaSeq and AlphaBind platforms to generate and analyze billions of protein-protein interaction data points. By combining high-throughput synthetic biology experiments with machine learning, A-Alpha Bio accelerates antibody discovery, targeted protein degradation, and the development of high-impact medicines for cancer, infectious disease, and more.
Summary
A-Alpha Bio is an Artificial Intelligence company based in Seattle, United States, founded in 2017. It has raised $46.0M in total across 4 rounds, most recently a $22.4M Series A round in Jul 2023. Investors include Perceptive Xontogeny Ventures, Madrona Venture and Bill & Melinda Gates Foundation.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2023
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...